Skip to the content

FDA Medical Device Recalls (openFDA)

Roche Diagnostics Corporation: The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.

Recall number
Z-1979-2019
Recalling firm
Roche Diagnostics Corporation
Product
The Tina-quant lgA Gen.2 is an immunoturbidimetric assay. Anti-lgA antibodies react with antigen in the sample to form an antigen/antibody complex which is measured turbidimetrically.
Status
Terminated
Initiated
2019-06-03
Posted
not on file
Terminated
2020-08-28
Reason
Calibration failures with Std.E, Sens.E, or Dup.E error due to atypical reaction kinetics and quality control failures have occurred due to contamination of R1 reagent with R3 reagent.
Root cause
Material/Component Contamination
Action
Urgent Medical Device Correction notification letters dated 6/3/19 were sent to customers.
Quantity
8 units
Distribution
The products were distributed to the following US states: AL, IN, and KY.
Lot, serial or model codes
Lot 368756
510(k) numbers
["K040435"]
PMA numbers
not on file
Product code
CZP
Firm FEI
1823260
Firm city
Indianapolis
Firm state
IN
Firm country
not on file

Where this comes from

Register
FDA Medical Device Recalls (openFDA)
Publisher
U.S. Food and Drug Administration (openFDA)
File
device-recall-0001-of-0001.json.zip
sha256
b87518bfe2e8
Size
288210821 bytes
Published
2026-09-28
Read
2026-09-29T08:25:23.626Z
Source file
Source file retained · verify
Refresh due
2026-10-06

Unless otherwise noted, the content, data, documentation, code, and related materials on openFDA is public domain and made available with a Creative Commons CC0 1.0 Universal dedication.

Cite as

FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28

Search this register